高级检索
当前位置: 首页 > 详情页

Quercetin acts via the G3BP1/YWHAZ axis to inhibit glycolysis and proliferation in oral squamous cell carcinoma

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Wuhan Univ, Tongren Hosp, Wuhan Hosp 3, Dept Cosmet Surg, Wuhan, Peoples R China [2]Wuhan Univ, Tongren Hosp, Wuhan Hosp 3, Dept Pharm, 241 Peng Liuyang Rd, Wuhan, Peoples R China
出处:
ISSN:

关键词: Quercetin oral squamous cell carcinoma glycolysis proliferation G3BP1

摘要:
There is increasing evidence that the GTPase-activating protein SH3 domain-binding protein 1 (G3BP1) plays important roles in the formation of various tumors. However, the biological functions and mechanism of G3BP1 in promoting the progression of oral squamous cell carcinoma remain largely unknown. The impacts of quercetin on glycolysis and proliferation of the CAL27 oral squamous cell carcinoma line were investigated, and the mediating role of the G3BP1/YWHAZ pathway was explored. CAL27 cells stably over- or underexpressing G3BP1 were treated with quercetin, and then cell proliferation was assayed together with the expression of proteins involved in glucose uptake, glycolysis, and lactate production, as well as the activity of hexokinase, pyruvate kinase, and lactate dehydrogenase. CAL27 cells expressed G3BP1 and YWHAZ at significantly higher levels than normal oral squamous cells. CAL27 cells showed the highest expression of both proteins among the three carcinoma lines (TSCCA, SCC15, 42 CAL27). Overexpressing G3BP1 in CAL27 cells markedly induced glucose uptake, glycolysis, cell proliferation, and YWHAZ expression. Knocking down G3BP1 or YWHAZ exerted the opposite effects, which were similar to the effects of inhibiting glycolysis. Quercetin repressed glucose uptake, glycolysis, cell proliferation, and G3BP1/YWHAZ signaling in a dose-dependent way, and these effects were antagonized by G3BP1 overexpression. Quercetin can inhibit glycolysis and cell proliferation of oral squamous cell carcinoma, apparently by inhibiting the G3BP1/YWHAZ axis.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 4 区 医学
小类 | 4 区 毒理学
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 毒理学
JCR分区:
出版当年[2021]版:
Q2 TOXICOLOGY
最新[2023]版:
Q2 TOXICOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]Wuhan Univ, Tongren Hosp, Wuhan Hosp 3, Dept Cosmet Surg, Wuhan, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [2]Wuhan Univ, Tongren Hosp, Wuhan Hosp 3, Dept Pharm, 241 Peng Liuyang Rd, Wuhan, Peoples R China [*1]Department of Pharmacy, Wuhan Third Hospital (Tongren Hospital of Wuhan University), No. 241 Peng Liuyang Road, Wuhan, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:21169 今日访问量:0 总访问量:1219 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)